Suppr超能文献

肺功能正常者慢性呼吸系统症状的预后意义。

Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.

机构信息

Dept of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

出版信息

Eur Respir J. 2019 Sep 19;54(3). doi: 10.1183/13993003.00734-2019. Print 2019 Sep.

Abstract

Normal spirometry is often used to preclude airway disease in individuals with unspecific respiratory symptoms. We tested the hypothesis that chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.We included 108 246 randomly chosen individuals aged 20-100 years from a Danish population-based cohort study. Normal spirometry was defined as a pre-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio ≥0.70. Chronic respiratory symptoms included dyspnoea, chronic mucus hypersecretion, wheezing and cough. Individuals with known airway disease, chronic obstructive pulmonary disease and/or asthma, were excluded (n=10 291). We assessed risk of hospitalisations due to exacerbations of airway disease and pneumonia, and respiratory and all-cause mortality, from 2003 through 2018.52 999 individuals had normal spirometry without chronic respiratory symptoms and 30 890 individuals had normal spirometry with chronic respiratory symptoms. During follow-up, we observed 1037 hospitalisations with exacerbation of airway disease, 5743 hospitalisations with pneumonia and 8750 deaths, of which 463 were due to respiratory disease. Compared with individuals with normal spirometry without chronic respiratory symptoms, multivariable adjusted hazard ratios for individuals with normal spirometry with chronic respiratory symptoms were 1.62 (95% CI 1.20-2.18) for exacerbation hospitalisations, 1.26 (95% CI 1.17-1.37) for pneumonia hospitalisations, 1.59 (95% CI 1.22-2.06) for respiratory mortality and 1.19 (95% CI 1.13-1.25) for all-cause mortality. There was a positive dose-response relationship between number of symptoms and risk of outcomes. Results were similar after 2 years of follow-up, for never-smokers alone, and for each symptom separately.Chronic respiratory symptoms are associated with respiratory hospitalisations and death in individuals with normal spirometry without known airway disease.

摘要

正常的肺功能检查常用于排除有非特异性呼吸系统症状的个体的气道疾病。我们检验了这样一个假设,即慢性呼吸系统症状与无已知气道疾病的正常肺功能检查个体的呼吸系统住院和死亡有关。

我们纳入了一项丹麦基于人群的队列研究中随机选择的 108246 名 20-100 岁的个体。正常的肺功能检查定义为支气管扩张剂前 1 秒用力呼气量/用力肺活量比≥0.70。慢性呼吸系统症状包括呼吸困难、慢性黏液高分泌、喘息和咳嗽。已知气道疾病、慢性阻塞性肺疾病和/或哮喘的个体被排除在外(n=10291)。我们评估了 2003 年至 2018 年期间因气道疾病恶化和肺炎导致的住院风险,以及呼吸系统和全因死亡率。

5299 名个体的肺功能检查正常且无慢性呼吸系统症状,30890 名个体的肺功能检查正常且有慢性呼吸系统症状。在随访期间,我们观察到 1037 例气道疾病恶化导致的住院,5743 例肺炎导致的住院和 8750 例死亡,其中 463 例归因于呼吸系统疾病。与肺功能检查正常且无慢性呼吸系统症状的个体相比,肺功能检查正常且有慢性呼吸系统症状的个体发生恶化住院的多变量校正危险比为 1.62(95%CI 1.20-2.18),发生肺炎住院的危险比为 1.26(95%CI 1.17-1.37),发生呼吸系统死亡的危险比为 1.59(95%CI 1.22-2.06),发生全因死亡的危险比为 1.19(95%CI 1.13-1.25)。症状数量与结局风险之间存在正剂量-反应关系。在 2 年的随访后、仅在从不吸烟者中以及分别针对每个症状进行分析时,结果均相似。

在无已知气道疾病的正常肺功能检查个体中,慢性呼吸系统症状与呼吸系统住院和死亡有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验